M. Dinubile

发表

Concomitant Use of an Oral Live Pentavalent Human-Bovine Reassortant Rotavirus Vaccine With Licensed Parenteral Pediatric Vaccines in the United States

Penny M Heaton, Zoe M Rodriguez, Michelle G. Goveia, 2007, The Pediatric infectious disease journal.

HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.

D. Mehrotra, R. Mogg, M. Lally, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

F. Baquero, D. Paterson, G. Bochicchio, 2006, Surgical infections.

Antibiotics: the antipyretics of choice?

M. Dinubile, 1990, The American journal of medicine.

Prophylactic use of antibiotics and vaccines in patients with rheumatologic disorders.

K. Mounzer, M. Dinubile, 1997, Rheumatic diseases clinics of North America.

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases

E. Gotuzzo, C. Sable, M. Dinubile, 2002, Antimicrobial Agents and Chemotherapy.

Surgery in active endocarditis.

M. Dinubile, 1982, Annals of internal medicine.

Septic cortical thrombophlebitis.

F. Southwick, M. Dinubile, W. H. Boom, 1990, The Journal of infectious diseases.

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

F. Baquero, D. Paterson, G. Bochicchio, 2006, The Journal of antimicrobial chemotherapy.

Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine Based on Breastfeeding Frequency

Penny M Heaton, Michelle G. Goveia, M. Dallas, 2008, The Pediatric infectious disease journal.

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

J. Chodakewitz, D. Denning, A. Saah, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease

T. Stossel, D. Kuhns, H. Malech, 2020, Inflammation.

Adjunctive treatment of severe sepsis.

M. Dinubile, 2013, The Lancet. Infectious diseases.

Therapeutic potential of plasma gelsolin administration in a rat model of sepsis.

Nicholas J. Ciccarelli, P. Janmey, S. Margulies, 2011, Cytokine.

Understanding the high infectious disease mortality among patients receiving hemodialysis: Potential risk of concurrently low cathelicidin and gelsolin levels.

M. Dinubile, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Editorial Plasma gelsolin as a biomarker of inflammation

M. Dinubile, 2008 .

Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin".

M. Dinubile, 2007, American journal of physiology. Cell physiology.

Recombinant Plasma Gelsolin Diminishes the Acute Inflammatory Response to Hyperoxia in Mice

T. Stossel, S. Goelz, J. Christie, 2002, Journal of Investigative Medicine.

Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.

T. Stossel, J. Ferrara, M. Dinubile, 2002, Blood.

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.

J. Smietana, E. Gotuzzo, N. Kartsonis, 2002, The American journal of medicine.

High concentrations of phosphatidylinositol-4,5-bisphosphate may promote actin filament growth by three potential mechanisms: inhibiting capping by neutrophil lysates, severing actin filaments and removing capping protein-beta2 from barbed ends.

M. Dinubile, S. Huang, Sherry Huang, 1997, Biochimica et biophysica acta.

Nodular Lymphangitis: A Distinctive but Often Unrecognized Syndrome

J. Kostman, M. Dinubile, 1993, Annals of Internal Medicine.

Skepticism: a lost clinical art.

M. Dinubile, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

J. Kublin, D. Mehrotra, J. Shiver, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Indinavir did not further increase mean triglyceride levels in HIV‐infected patients treated with nucleoside reverse transcriptase inhibitors: An analysis of three randomized clinical trials

H. Guess, M. Dinubile, T. Rhodes, 2003, Pharmacoepidemiology and drug safety.

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies

C. Katlama, Y. Yazdanpanah, K. Squires, 2017, Open forum infectious diseases.

Combination of vaniprevir with peginterferon and ribavirin significantly increases the rate of SVR in treatment-experienced patients with chronic HCV genotype 1 infection and cirrhosis.

E. Gane, E. Lawitz, L. Serfaty, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.

A. Lazzarin, M. Saag, J. Rockstroh, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

P. Hsueh, J. Chow, M. Dinubile, 2006, International journal of antimicrobial agents.

Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit

C. A. Wood, G. Woods, M. Dinubile, 2006, European Journal of Clinical Microbiology and Infectious Diseases.

Efficacy of Boceprevir / Peginterferon / Ribavirin for HCV G 1 Compensated Cirrhotics : Meta-Analysis of 5 Trials

M. Manns, B. Bacon, K. Koury, 2014 .

Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.

M. Manns, B. Bacon, K. Koury, 2014, Journal of hepatology.

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

P. Marcellin, J. Albrecht, S. Zeuzem, 2012, Hepatology.

Spinal epidural abscess

M. Dinubile, 2021, Schlossberg's Clinical Infectious Disease.

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.

E. Gotuzzo, C. Sable, M. Dinubile, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection.

D. Nickle, A. Howe, R. Barnard, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.

G. Woods, M. Dinubile, K. Mccarroll, 2004, Pulmonary pharmacology & therapeutics.

Nonnucleotide reverse-transcriptase inhibitors and treatment interruption.

M. Dinubile, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of endocarditis caused by relatively resistant nonenterococcal streptococci: is penicillin enough?

M. Dinubile, 1990, Reviews of infectious diseases.

Complicated infections of skin and skin structures: when the infection is more than skin deep.

Benjamin A Lipsky, M. Dinubile, 2004, The Journal of antimicrobial chemotherapy.

Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants

R. K. Evans, D. Mehrotra, R. Leavitt, 2014, Open forum infectious diseases.

Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

D. Mehrotra, J. Shiver, R. Leavitt, 2009, Clinical and Vaccine Immunology.

Nodular lymphangitis: A distinctive clinical entity with finite etiologies

M. Dinubile, Mark J. DiNubile, 2008, Current infectious disease reports.

Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study

M. Kivimäki, T. Strandberg, M. Dinubile, 2022, Aging Clinical and Experimental Research.

Cardiac conduction abnormalities complicating native valve active infective endocarditis.

S. Calderwood, D. Steinhaus, A. Karchmer, 1986, The American journal of cardiology.

Heart block during bacterial endocarditis: a review of the literature and guidelines for surgical intervention.

M. Dinubile, 1984, The American journal of the medical sciences.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

J. Heyse, K. O'Brien, P. van Damme, 2006, The New England journal of medicine.

Distribution of rotavirus genotypes causing nosocomial and community-acquired acute gastroenteritis at The Children's Hospital of Philadelphia in the new rotavirus vaccine era

J. Matthijnssens, D. Distefano, M. Dinubile, 2011, Human vaccines.

Pentavalent Rotavirus Vaccine in Developing Countries: Safety and Health Care Resource Utilization

Penny M Heaton, M. Dinubile, R. Itzler, 2010, Pediatrics.

Sustained Decline in Cases of Rotavirus Gastroenteritis Presenting to the Children's Hospital of Philadelphia in the New Rotavirus Vaccine Era

J. Matthijnssens, M. Dinubile, R. Hodinka, 2010, The Pediatric infectious disease journal.

Decline in Cases of Rotavirus Gastroenteritis Presenting to The Children's Hospital of Philadelphia after Introduction of a Pentavalent Rotavirus Vaccine

M. Dinubile, R. Hodinka, D. Lawley, 2009, Clinical and Vaccine Immunology.

Impact of Acute Rotavirus Gastroenteritis on Pediatric Outpatient Practices in the United States

S. Coffin, Michelle G. Goveia, J. Stek, 2006, The Pediatric infectious disease journal.

Septic thrombosis of the cavernous sinuses.

M. Dinubile, 1988, Archives of neurology.

Necrotizing fasciitis in adults due to group B streptococcus. Report of a case and review of the literature.

M. Dinubile, A. Molavi, D. Schwartz, 1988, Archives of internal medicine.

Response Letter to Dr. Raschilas et al.

M. Dinubile, K. Mccarroll, I. Friedland, 2004 .

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients

P. Janmey, L. Montaner, E. Papasavvas, 2009, AIDS (London).

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

J. Chodakewitz, C. Sable, M. Dinubile, 2002, Transplant infectious disease : an official journal of the Transplantation Society.

Long-Term Efﬁcacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor–Naive Adults with Advanced HIV Infection

M. Hirsch, B. Hirschel, R. Leavitt, 2003 .

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

E. Anaissie, J. Perfect, A. Reboli, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza

T. Stossel, Q. Lu, L. Kobzik, 2019, F1000Research.

Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza.

T. Stossel, Q. Lu, L. Kobzik, 2019, F1000Research.

Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention

M. Shivaprakash, R. Raz, F. Köckerling, 2006, Journal of Gastrointestinal Surgery.

Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy

J. Quinn, R. Weinstein, M. Shivaprakash, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

F. Baquero, H. Teppler, D. Paterson, 2005, The Journal of antimicrobial chemotherapy.

Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections.

M. Shivaprakash, M. Dinubile, F. Branicki, 2005, International journal of surgery.

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).

J. Chow, Charlotte M. Harvey, M. Dinubile, 2005, Surgical infections.

Temporal association between serum gelsolin levels and clinical events in a patient with severe falciparum malaria.

M. Dinubile, S. Huang, S. Rhoads, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Paradoxical interpretations of noninferiority studies: violating the excluded middle

J. Eron, R. Lupinacci, M. Dinubile, 2012 .

Rigor in the design of observational noninferiority trials.

M. Dinubile, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors

Najaf A. Shah, A. Joshi, F. Lupu, 2014, Human vaccines & immunotherapeutics.

Amphotericin B lipid complex in pediatric patients with invasive fungal infections.

S. Chanock, Richard E. Harris, A. Reboli, 1999, The Pediatric infectious disease journal.

Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans

R. Betts, H. Greenberg, W. Orenstein, 2010, Clinical and Vaccine Immunology.

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia

M. Dinubile, S. Parra, S. Levinson, 2022, Open forum infectious diseases.

Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia

M. Dinubile, J. Catteeuw, 2021, Clinical Infection in Practice.

Does bedside rationing violate patients' best interests? An exploration of "moral hazard".

M. Dinubile, 1998, The American journal of medicine.

Surgery for addiction-related tricuspid valve endocarditis: caveat emptor.

M. Dinubile, 1987, The American journal of medicine.

Raltegravir with optimized background therapy for resistant HIV-1 infection.

D. Hazuda, B. Clotet, C. Katlama, 2008, The New England journal of medicine.

Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK

A. Lazzarin, M. Saag, J. Rockstroh, 2012, HIV Clinical Trials.

Erythrocyte membrane fractions contain free barbed filament ends despite sufficient concentrations of retained capper(s) to prevent barbed end growth.

M. Dinubile, 1999, Cell motility and the cytoskeleton.

Capping of the barbed ends of actin filaments by a high-affinity profilin-actin complex.

M. Dinubile, S. Huang, 1997, Cell motility and the cytoskeleton.

Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis

J. Perfect, M. Motyl, A. Colombo, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Transesophageal echocardiograms in patients with catheter-derived Staphylococcus aureus bacteremia.

M. Dinubile, 2012, The American journal of medicine.

Erectile dysfunction in an urban HIV-positive population.

K. Mounzer, M. Dinubile, V. Lo Re, 2006, AIDS patient care and STDs.

Nucleation and elongation of actin filaments in the presence of high speed supernate from neutrophil lysates: modulating effects of Ca2+ and phosphatidylinositol-4,5-bisphosphate.

M. Dinubile, 1998, Biochimica et biophysica acta.

Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.

N. Kartsonis, C. Sable, K. Bartizal, 2002, Journal of acquired immune deficiency syndromes.

Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin.

C. Sable, R. Lupinacci, M. Dinubile, 2002, AIDS research and human retroviruses.

Allogeneic Stem Cell Transplantation Prognostic Implications of Declining Plasma Gelsolin Levels After

T. Stossel, J. Ferrara, M. Dinubile, 2002 .

Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis

G. Aronoff, L. Mailloux, N. Kartsonis, 2012, Clinical and Vaccine Immunology.

Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods

D. Bernstein, R. Ward, P. Azimi, 2012, Journal of paediatrics and child health.

Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir

A. Howe, P. Jumes, S. Black, 2015, Antimicrobial Agents and Chemotherapy.

Susceptibilities of Genotype 1 a , 1 b , and 3 Hepatitis C Virus Variants to the NS 5 A Inhibitor Elbasvir

A. Howe, P. Jumes, S. Black, 2015 .

Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin

J. Howe, A. Howe, J. Long, 2014, Open forum infectious diseases.

Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: a population and clonal analysis.

D. Hazuda, D. Nickle, D. Graham, 2013, Virology.

Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study

H. Teppler, T. Walsh, B. D. de Pauw, 2006, Transplant infectious disease : an official journal of the Transplantation Society.

Invasive colitis and hepatitis due to previously uncharacterized spirochetes in patients with advanced human immunodeficiency virus infection.

J. Kostman, M. Dinubile, E. Catalano, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent.

M. Buti, X. Forns, A. Howe, 2015, Journal of hepatology.

Boceprevir for untreated chronic HCV genotype 1 infection.

M. Manns, J. Albrecht, K. Reddy, 2011, The New England journal of medicine.

Short-Course Antibiotic Therapy for Right-Sided Endocarditis Caused by Staphylococcus aureus in Injection Drug Users

M. Dinubile, Mark DiNubile, 1994, Annals of Internal Medicine.

Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infections

A. Meibohm, N. Kartsonis, C. Sable, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation

Michael Boeckh, Yoshinobu Kanda, Hermann Einsele, 2017, The New England journal of medicine.

Pneumococcal soft-tissue infections: a problem deserving more recognition.

M. Dinubile, D. Moyer, M. Patel, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Adriano Lazzarin, Edwin DeJesus, Peter Sklar, 2009, The Lancet.

Therapeutic role of granulocyte transfusions.

M. Dinubile, 1985, Reviews of infectious diseases.

Caspofungin: the first licensed antifungal drug of the novel echinocandin class

M. Motyl, C. Sable, M. Dinubile, 2004 .

Invasive candidiasis in cancer patients: observations from a randomized clinical trial.

N. Kartsonis, C. Sable, M. Dinubile, 2005, The Journal of infection.

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

R. Ward, T. Vesikari, P. Offit, 2006, Vaccine.

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

D. Hazuda, B. Clotet, C. Katlama, 2008, The New England journal of medicine.

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial.

Jing Zhao, Christine Katlama, Benjamin Young, 2011, The Lancet. Infectious diseases.

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

M. Buti, X. Forns, A. Howe, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prednisolone or Pentoxifylline for Alcoholic Hepatitis.

M. Dinubile, 2015, The New England journal of medicine.

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK

Y. Yazdanpanah, M. Saag, J. Rockstroh, 2013, Journal of acquired immune deficiency syndromes.

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

D. Cooper, M. Youle, R. Leavitt, 2010, The Lancet.

Actin filament barbed-end capping activity in neutrophil lysates: the role of capping protein-beta 2.

S. Zigmond, L. Cassimeris, L Cassimeris, 1995, Molecular biology of the cell.

Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus

R. Kirsner, D. Margolis, S. Thom, 2023, ImmunoHorizons.

Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.

S. Thom, M. Dinubile, V. Bhopale, 2021, Journal of applied physiology.

Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.

G. Archer, S. Calderwood, A. Karchmer, 1987, The American journal of medicine.

Stopping antibiotic therapy in neutropenic patients.

M. Dinubile, 1988, Annals of internal medicine.

Acute syphilitic meningitis in a man with seropositivity for human immunodeficiency virus infection and normal numbers of CD4 T lymphocytes.

T. Mirsen, M. Dinubile, J. Baxter, 1992, Archives of internal medicine.

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.

M. Dinubile, D. Nix, A. Majumdar, 2004, The Journal of antimicrobial chemotherapy.

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

R. Betts, V. Fowler, Y. Carmeli, 2013, JAMA.

Pneumococcal soft-tissue infections: possible association with connective tissue diseases.

L. Bush, M. A. Albornoz, M. Dinubile, 1991, The Journal of infectious diseases.

An immune-based biomarker signature is associated with mortality in COVID-19 patients

L. Notarangelo, K. Dobbs, J. Tsang, 2020, JCI insight.

GrazoprevirElbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

K. Reddy, S. Zeuzem, J. Butterton, 2015, Annals of Internal Medicine.

Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.

J. Kublin, C. del Rio, D. Mehrotra, 2010, The Journal of infectious diseases.

Changes in Plasma Gelsolin Concentration During Acute Oxidant Lung Injury in Mice

V. Muzykantov, S. Albelda, A. Scherpereel, 2002, Lung.

Plasma gelsolin levels are associated with diabetes, sex, race, and poverty

A. Zonderman, M. Evans, N. Mode, 2023, Journal of Translational Medicine.

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

A. Lazzarin, Jinrong Zhao, R. Leavitt, 2010, Journal of acquired immune deficiency syndromes.

Premastication: a possible missing link?

M. Dinubile, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

R. Zeldin, M. Fischl, M. Dinubile, 2002, Journal of acquired immune deficiency syndromes.

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

N. Muñoz, S. Kjaer, S. Garland, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.

D. Mehrotra, M. Mulligan, J. Shiver, 2009, AIDS research and human retroviruses.

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.

A. Saah, M. Berkovitch, S. Block, 2016, JAMA.

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.

A. Saah, M. Berkovitch, S. Block, 2016, JAMA.

Receiving Hemodialysis - A Phase IIa Study

G. Aronoff, L. Mailloux, N. Kartsonis, 2012 .

Unexpectedly high burden of rotavirus gastroenteritis in very young infants

M. Dinubile, D. Lawley, H. Clark, 2010, BMC pediatrics.

The Ciguatera Poisoning Syndrome from Farm-Raised Salmon

Y. Hokama, M. Dinubile, Mark DiNubile, 1995, Annals of Internal Medicine.

An unusual outbreak of rotavirus genotype G2P[6] during the 2005-2006 epidemic season in Philadelphia.

D. Distefano, M. Dinubile, D. Lawley, 2011, Diagnostic microbiology and infectious disease.

Safety and Efficacy of the Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine in Healthy Premature Infants

Penny M Heaton, Zoe M Rodriguez, Michelle G. Goveia, 2007, The Pediatric infectious disease journal.

Responsibility for patient care: where does the buck stop?

M. Dinubile, 1990, The American journal of medicine.

Neurosyphilis developing during treatment of secondary syphilis with benzathine penicillin in a patient without serologic evidence of human immunodeficiency virus infection.

M. Dinubile, F. J. Copare, K. M. Gekowski, 1990, The American journal of medicine.

Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.

F. Southwick, M. Dinubile, 1985, The Journal of biological chemistry.

Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.

H. Maradit-Kremers, M. Dinubile, P. Coplan, 2003, AIDS research and human retroviruses.

Leprosy: forgotten, but not gone (yet)

M. Dinubile, Jay S. Keystone, 2011, International Journal of Dermatology.

Subdural empyema and cranial epidural abscess.

A. Silverberg, M. Dinubile, Alan L. Silverberg, 1985, The Medical clinics of North America.

Clinical significance of staphylococcus aureus bacteriuria without concurrent bacteremia.

M. Dinubile, S. Sheth, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.

J. Quinn, R. Weinstein, M. Shivaprakash, 2007, Diagnostic microbiology and infectious disease.

Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections

H. Teppler, M. Motyl, J. Chow, 2005, Antimicrobial Agents and Chemotherapy.

Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma.

K. Mounzer, M. Dinubile, M. Moncure, 1999, American journal of respiratory and critical care medicine.

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine

V. Fowler, K. Allen, J. Gammie, 2014, Open forum infectious diseases.

Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease

M. Dinubile, M. Saballs, S. Parra, 2023, Atherosclerosis Plus.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

C. Wheeler, F. X. Bosch, N. Muñoz, 2018, Obstetrics and gynecology.

Contrast effects in judgments of crime severity and the punishment of criminal violators.

A. Pepitone, M. Dinubile, 1976 .

Rabbit alveolar macrophages contain a Ca2+-sensitive, 41,000-dalton protein which reversibly blocks the "barbed" ends of actin filaments but does not sever them.

F. Southwick, M. Dinubile, 1986, The Journal of biological chemistry.

Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia

J. Bolognese, S. Opal, Abla Tannous, 2020, Antimicrobial Agents and Chemotherapy.

Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

T. Stossel, M. Lawrenz, Jonathan M. Warawa, 2020, Open forum infectious diseases.

Corticosteroids in ARDS.

M. Dinubile, 2006, The New England journal of medicine.

Antiviral Activity of ANA773, an Oral Inducer of Endogenous Interferons that Acts Via TLR7, in Chronic Hepatitis C Patients

B. Walker, S. Akira, J. Kaldor, 2011 .

Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials.

R. Leavitt, H. Guess, L. Doll, 2001, AIDS.

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.

S. Hammer, A. Wu, J. Heyse, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.

Joshua Chen, D. Haas, J. Condra, 2003, The Journal of infectious diseases.

Abbreviated therapy for right-sidedStaphylococcus aureus endocarditis in injecting drug users: The time has come?

M. Dinubile, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)

G. Koch, P. van Damme, D. Matson, 2010, BMC pediatrics.

Reliving a nightmare: a hard (and tragic) lesson in humility.

M. Dinubile, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.

N. Kartsonis, C. Sable, R. Lupinacci, 2007, Journal of critical care.

Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial

V. Fowler, M. Bonten, H. Jafri, 2018, PloS one.

Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.

W. Self, T. Stossel, R. Wunderink, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Double-blind active-control trials: beware the comparator you keep.

M. Dinubile, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)

T. Vesikari, D. Matson, Penny M Heaton, 2011, Human vaccines.

Corrigendum to "In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)" (Int. J. Antimicrob. Agents 28 (2006) 238-243)

P. Hsueh, J. Chow, M. Dinubile, 2009 .

Noninferior Antibiotics: When Is “Not Bad” “Good Enough”?

M. Dinubile, 2016, Open forum infectious diseases.

Bias and asymmetry in sequential noninferiority-superiority trial designs.

M. Dinubile, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Commentary re: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens. Infectious Diseases Society of America White Paper Clin Infect Dis. 2012;55:1031-46.

M. Dinubile, 2013 .

Universal prophylaxis, targeted prophylaxis, and/or preemptive therapy for opportunistic infections at the time of initiation of combination antiretroviral therapy for patients with advanced HIV Infection.

M. Dinubile, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

A. Lazzarin, R. Leavitt, R. Pollard, 2009, The Lancet.

Seminal human immunodeficiency virus blips and structured natural conception in serodiscordant couples.

K. Mounzer, M. Dinubile, 2013, Journal of Infectious Diseases.

GrazoprevirElbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

K. Reddy, S. Zeuzem, J. Butterton, 2015, Annals of Internal Medicine.

Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods

D. Bernstein, R. Ward, P. Azimi, 2012, Journal of paediatrics and child health.

[23] Contractile proteins in leukocytes

F. Southwick, M. Dinubile, 1988 .

O001 : C-salvage: grazoprevir (GZR; MK-5172), elbasvir (EBR; MK-8742) and ribavirin (RBV) for chronic hcv-genotype 1 (GT1) infection after failure of direct-acting antiviral (DAA) therapy

M. Buti, X. Forns, A. Howe, 2015 .

Corticosteroids in ARDS.

M. Dinubile, 2006, The New England journal of medicine.

M. Dinubile, 2009, Clinical Infectious Diseases.

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.

A. Lazzarin, M. Saag, J. Rockstroh, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Endocarditis: A Multidisciplinary Approach to Modern Treatment

M. Dinubile, 2000, Annals of Internal Medicine.

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients

P. Janmey, L. Montaner, E. Papasavvas, 2009, AIDS.